Hypnotherapy

Hypnotherapy is a trance practice developed within Western clinical medicine, with documented use spanning roughly two centuries. It is among the most extensively researched suggestion-based clinical interventions, with established evidence in procedural pain and irritable bowel syndrome.^[1] It alters consciousness primarily through suggestive absorption — sustained focused attention coupled with heightened receptivity to therapist-delivered suggestion.

The patient sits or reclines in a comfortable chair while a clinician guides an induction — typically eye fixation, progressive relaxation, or counting — to shift attention away from external stimuli toward an internal focus. The clinician then delivers targeted therapeutic suggestions appropriate to the treatment goal before reorienting the patient to ordinary waking consciousness. Sessions last 45 to 60 minutes and are conducted weekly across a course of treatment.

A typical session lasts 45 to 60 minutes. At introductory levels, patients commonly experience deep physical relaxation, narrowed awareness of surroundings, time distortion, and a sense of effortless absorption in the clinician's voice. Highly hypnotizable patients (roughly 10–15% of adults) report more vivid alterations: involuntary motor responses, sensory changes, and selective amnesia for session content.^[2] Transient drowsiness, mild disorientation, and emotional surfacing tied to suggestion content are common.

Serious adverse events are absent from the published trial literature.^[1] The empirically substantiated risk is false-memory creation when regression or memory-recovery techniques are used.^[3] Active psychosis, severe dissociative disorders, and severe paranoia are clinical contraindications. Hypnotherapy is among the most extensively studied suggestion-based interventions and is now integrated into European and North American gastroenterology guidelines as a treatment option for refractory irritable bowel syndrome.^[4]

Origins

Clinical hypnosis traces its origins to Franz Anton Mesmer (1734–1815), a Viennese physician who attributed therapeutic effects to an invisible fluid he called "animal magnetism." A 1784 royal commission in Paris that included Benjamin Franklin and Antoine Lavoisier concluded that the observed effects were attributable to imagination rather than any physical fluid. Mesmerism nonetheless transmitted the practical observation that focused attention and suggestion produced demonstrable physiological and psychological change.

The Scottish surgeon James Braid (1795–1860) gave the field its modern name and its first scientific framing. Observing that subjects who fixed their gaze on a small object fell into a trance-like state, Braid rejected magnetic explanations and proposed a neurological mechanism he called "neurypnology".^[5] He later reconceptualized the state as "monoideism" — the fixation of attention on a single idea — anticipating modern suggestion-based models.

Transmission and clinical professionalization

The late nineteenth century produced two rival schools. Ambroise-Auguste Liébeault and Hippolyte Bernheim at Nancy argued that hypnotic effects were products of ordinary suggestion accessible to most people. Jean-Martin Charcot at the Salpêtrière in Paris held that deep hypnosis was a pathological state akin to hysteria, restricted to certain individuals. Pierre Janet extended Charcot's work into a theory of psychological dissociation. Sigmund Freud trained with both Charcot and Bernheim, briefly adopted hypnosis, then abandoned it around 1896 in favour of free association — a departure that depressed the profile of clinical hypnosis for several decades.

Clark Hull's laboratory work at Yale, consolidated in Hypnosis and Suggestibility (1933), re-established hypnosis as a legitimate subject of experimental psychology. His insistence on controlled methodology and quantitative measurement shaped the next generation of researchers.

Milton Erickson (1901–1980) is the central figure of modern clinical practice. From the late 1920s through his death, Erickson developed an indirect, naturalistic style of induction that moved away from authoritarian "sleep" commands toward conversational suggestion, metaphor, and utilization of the patient's existing language and experience. His innovations — confusion techniques, paradoxical directives, embedded suggestions — remain embedded in most contemporary psychotherapy frameworks. Erickson co-founded the American Society of Clinical Hypnosis (ASCH) in 1957.^[6]

Contemporary context

The American Medical Association and the British Medical Association both endorsed hypnosis as a valid medical adjunct in 1958. The American Psychological Association formally organized Division 30, the Society of Psychological Hypnosis, in 1969.^[7] The Society for Clinical and Experimental Hypnosis (founded 1949) is the other major professional body; the two organizations collaboratively set training standards.

André Weitzenhoffer and Ernest Hilgard standardized the measurement of individual hypnotizability with the Stanford Hypnotic Susceptibility Scale, published in 1959.^[2] Hilgard later proposed neodissociation theory — that hypnosis splits executive monitoring from behavioral control — based on his "hidden observer" experiments. In the United States, hypnotherapy remains an adjunct practised under an underlying healthcare licence rather than an independently licensed profession; the unregulated wellness market operates alongside the clinical tradition without sharing its credentialing requirements.

Technique

The patient is seated upright in a comfortable chair or reclined on a couch, in a quiet room with subdued lighting and no significant external interruptions. No equipment beyond the therapist's voice is required for most inductions; a fixation object (a pen, a spot on the ceiling) is sometimes used in eye-fixation protocols. The patient is asked to wear ordinary clothing and is not required to close their eyes — many inductions begin with open-eye fixation and transition to closed eyes as relaxation deepens.

The method proceeds through four functional phases. The clinician first performs an induction — a verbal procedure that shifts the patient from alert waking consciousness toward focused absorption — typically using eye fixation, progressive muscular relaxation, counting, or imagery of descending a staircase. A deepening phase follows, in which further instructions stabilize and extend the state. The clinician then delivers therapeutic content — direct suggestions, ego-strengthening scripts, imagery rehearsal, metaphor, or symptom-specific protocols depending on the treatment goal. Finally, an emergence procedure (counting upward, brief verbal reorientation) returns the patient to ordinary waking consciousness. The most common departure from the method is the clinician phrasing suggestions as commands rather than invitations — authoritarian wording reduces engagement in most patients and triggers active resistance in some, while conversational and permissive wording recruits the patient's own imaginative involvement.

Hypnotherapy is goal-directed rather than progressive: there is no internal mastery arc and no formal stage map. What varies across the introductory and established tiers is the specificity of the protocol. At introductory level a single 45–60 minute session may target a simple outcome (presurgical anxiety, an isolated phobic response) using general relaxation and a brief targeted suggestion. At established level — a course of weekly sessions over several months with a qualified practitioner — structured protocols such as the Manchester gut-directed hypnotherapy curriculum address defined conditions (refractory IBS, chronic pain, smoking cessation) through sequenced symptom-specific suggestion across visits.^[8]

Two stylistic traditions divide contemporary practice. The classical, direct-suggestion approach descending from Bernheim and the early twentieth century employs explicit instruction ("your hand is becoming light"). The Ericksonian approach, dominant in much of modern clinical practice, employs indirect and conversational suggestion, embedded directives, and utilization of the patient's spontaneous language and behaviour. Specialized condition-specific protocols — gut-directed hypnotherapy for IBS, the Elkins protocol for menopausal hot flashes,^[9] and presurgical hypnosis modelled on the Montgomery protocol^[10] — overlay these stylistic choices with structured scripts and dosing schedules.

Setting & Preparation

Hypnotherapy is delivered in a private clinical room — therapist's office, hospital consult room, or comparable setting — that is quiet, with no significant ambient noise, and softly lit. The patient is seated in a recliner or armchair, or supine on a treatment couch. No specialized equipment is required: the clinician's voice carries the entire intervention. A clock or timer is used informally to track session duration. Headphones and recorded inductions are sometimes used for between-session practice but are an adjunct rather than the primary modality. A qualified clinician — licensed in an underlying healthcare profession and trained in hypnosis through ASCH, SCEH, APA Division 30, or an equivalent body — is required for clinical applications.^[6]

A qualified, licensed practitioner is the single most important harm-reduction factor for hypnotherapy. The wellness market includes a substantial population of uncredentialed lay hypnotherapists; clinical applications — pain, IBS, smoking cessation, anxiety — should be conducted by a clinician licensed in an underlying healthcare profession (medicine, psychology, clinical social work, counseling, dentistry) and certified through ASCH, SCEH, APA Division 30, or an equivalent national body.^[6]

The physical setting is a private, quiet room with subdued lighting, no significant external interruptions, and a comfortable chair or couch. The patient should be in good general health for the day of the session — not acutely ill, not significantly intoxicated, not sleep-deprived to the point that the relaxation phase risks unintended sleep. Before the first session, the clinician should take a clinical history including any psychiatric diagnoses, medications, history of trauma, and substance use, and should assess hypnotizability at intake using a validated instrument when appropriate.

Pain affect modulation

Rainville and colleagues demonstrated in a landmark 1997 PET study that hypnotic suggestions targeting the affective dimension of pain (unpleasantness) produced corresponding changes in anterior cingulate cortex activity without altering primary somatosensory cortex activation.^[11] This dissociation established that hypnosis selectively alters the affective processing of nociceptive input rather than blocking sensory transmission. Faymonville and colleagues extended the finding with PET evidence that hypnotic antinociception is associated with increased functional connectivity between the anterior cingulate and a network of regions including the thalamus and brain stem, consistent with top-down modulation of pain gating.^[12]

Network reorganization

Jiang and colleagues at Stanford used resting-state fMRI in 57 participants stratified by hypnotizability and observed three distinct changes during hypnosis in highly hypnotizable individuals: reduced activity in the dorsal anterior cingulate cortex (a salience-network hub), increased functional connectivity between the dorsolateral prefrontal cortex and the insula, and reduced anticorrelation between the executive control network and the default mode network.^[13] The profile suggests that hypnosis reorganizes the coupling between self-monitoring and executive control systems rather than producing a uniform "deactivation." A single-case combined fMRI/EEG study of a "hypnotic virtuoso" found altered and asymmetric default-mode-network activity during undisturbed hypnosis that was absent in non-hypnotic rest.^[14]

Autonomic and electrophysiological correlates

EEG studies report increased theta-band power and frontal coherence during hypnotic induction; the magnitude of the theta increase correlates modestly with hypnotizability scores. Alpha-band findings are inconsistent across studies, and no EEG signature reliably distinguishes hypnosis from deeply relaxed wakefulness in low-to-medium hypnotizability subjects [UNCITED — verify: specific EEG meta-analysis on theta correlation with SHSS]. Heart rate variability and autonomic measures generally show that relaxation-based inductions reduce sympathetic tone and increase parasympathetic activity, as would any effective relaxation procedure; specific suggestions for anxiety or pain imagery can reverse this profile, confirming that autonomic changes are mediated by suggestion content rather than trance depth alone.

Hypnotizability is a stable individual trait with a roughly normal distribution: approximately 10–15% of adults are highly hypnotizable, 15–20% are minimally responsive, and the majority occupy an intermediate range.^[2] Higher hypnotizability is associated with larger neural effects and larger clinical effect sizes in most outcome domains.

Hypnotic experience varies systematically with individual hypnotizability and with the content of the suggestions delivered. At light to medium depth — the range reached by most patients in clinical practice — characteristic phenomena include deep physical relaxation, narrowed awareness of external stimuli, an altered sense of time (most often time contraction), and a sense of effortless absorption in the clinician's voice. Suggested motor responses (arm levitation, hand catalepsy) occur in a sizeable minority of patients without subjective sense of voluntary effort. Suggested sensory and perceptual changes — analgesia, altered taste, visual imagery — are accessible to highly hypnotizable patients and produce measurable behavioural and physiological effects.^[11]

The condition-specific clinical literature documents the outcomes that match these phenomenological reports. Procedural anxiety and acute pain are substantially reduced in surgical and biopsy settings.^[10][16] Gut-directed hypnotherapy reduces overall bowel symptom severity in IBS patients with effects sustained at 12 months.^[8] Hot flash frequency and severity in post-menopausal women decline substantially with the Elkins protocol.^[9] Unsought effects include transient drowsiness, mild disorientation immediately after emergence, headache, and emotional surfacing when suggestion content engages unresolved material. Selective amnesia for session content occurs in highly hypnotizable subjects, sometimes spontaneously and sometimes in response to explicit suggestion.

Adverse Effects

Contraindications

Absolute contraindications

• Active psychosis or schizophrenia spectrum disorder — risk of confusion between hypnotic and psychotic ideation, and of symptom exacerbation through immersive suggestion.
• Severe dissociative disorders (e.g., dissociative identity disorder) — unless delivered by a clinician with specialist trauma training, as further dissociation may compound symptoms.
• Severe paranoia — the suggestible state can be reinterpreted as external control and worsen persecutory experience.

Relative contraindications

• Active major depressive episode with suicidal ideation, unless hypnotherapy is integrated into a broader treatment plan with appropriate risk management.
• Severe personality disorders without a supportive treatment framework.
• Epilepsy when inductions incorporate hyperventilatory breathing changes — a theoretical seizure-threshold concern without controlled-study evidence [UNCITED — verify: specific case-report or guideline language on epilepsy + breathing-based induction].

There is no published documentation of hypnotherapy triggering psychotic episodes in individuals without pre-existing psychosis risk, though the systematic absence of adverse event reporting across trials means rare events cannot be ruled out.^[1]

Substance Interactions

No controlled studies have characterized pharmacodynamic or pharmacokinetic interactions between hypnotherapy and psychoactive substances. The evidence gap is complete for most substance classes.

The most commonly cited theoretical concern is additive CNS depression when hypnotherapy is conducted in combination with sedatives, benzodiazepines, opioids, or other anxiolytics. Relaxation-based inductions deepen pharmacologically produced sedation, which can impair the patient's ability to engage with suggestion content and to report on their state — a clinical-practice concern rather than an established interaction. Clinicians generally prefer that patients are not acutely intoxicated during sessions. A 2023 RCT of hypnotherapy for chronic pain in 378 veterans reported a substantial reduction in risk of daily cannabis use at six-month follow-up as a secondary outcome, with no statistically significant effect on alcohol use [UNCITED — verify: specific 2023 veteran chronic-pain hypnotherapy RCT cannabis substudy].

No literature characterizes hypnotherapy combined with classic psychedelics, dissociatives, or MDMA. The combination would raise significant safety questions — unpredictable amplification of suggestion effects, inability to distinguish hypnotic and substance phenomenology — but the concern is speculative and untested.

Habituation

Compulsive use of hypnotherapy is not a documented pattern in the clinical literature. Patients do not typically develop dependence on therapist-led sessions, and treatment is bounded by goal achievement rather than open-ended attendance. Some patients report enjoying the relaxation phase of sessions and request additional appointments after the primary therapeutic goal is met; this is a benign clinical pattern rather than a habituation syndrome.

A separate but related concern arises with self-hypnosis recordings used between sessions: a small subset of patients develops a reliance on the recording for relaxation or sleep onset. This is closer to a sleep-aid dependency pattern than a hypnosis-specific risk, and is readily addressed through clinician-guided tapering when it occurs [UNCITED — verify: published case reports or surveys of self-hypnosis recording dependence].

If Distress Arises

The patient retains full agency throughout a hypnotherapy session and can stop at any time. The standard exit is to open the eyes, sit up, and tell the clinician you wish to end the session — a competent practitioner will respond by guiding a brief emergence procedure to return you to ordinary alertness.

Reduce engagement or end the session if: suggestion content begins to surface unresolved trauma without therapeutic framing, you find yourself unable to distinguish the clinician's suggestions from your own thoughts in a way that feels intrusive, paranoid or persecutory ideation emerges, or you experience significant somatic distress (chest pain, severe dizziness, breathing difficulty). If you feel disoriented after the formal emergence procedure, ask the clinician to extend the reorientation phase — count more slowly, name objects in the room, drink water — before standing or driving.

Emotional surfacing during a session is not in itself a reason to stop; managed disclosure of difficult material is part of the therapeutic process. The signal that warrants stopping is loss of trust in the clinician or a sense that the work is moving faster than you can integrate.

Hypnotherapy does not employ a progression or stage model. Treatment is goal-directed: the number of sessions is determined by the target condition, not by the patient's advancing mastery of an internal state. A typical session moves through four functional phases — induction, deepening, therapeutic work, and emergence — and an established course of treatment for a defined condition (refractory IBS, chronic pain, smoking cessation) may run six to twelve weekly sessions before review. Trance depth is sometimes informally categorized as light, medium, or somnambulistic, but no validated stage map governs treatment decisions and depth correlates only weakly with outcome for most conditions. Individual hypnotizability, assessed at intake with the Stanford Hypnotic Susceptibility Scale or the Hypnotic Induction Profile, is the primary predictor of response magnitude.^[2]

The most comprehensive synthesis of the hypnotherapy literature is Rosendahl, Alldredge, and Haddenhorst's 2024 umbrella review of 49 meta-analyses encompassing 261 distinct primary studies.^[1] Reported effect sizes spanned d = −0.04 to d = 2.72; roughly a quarter of effects were medium-sized (d ≥ 0.5) and a further quarter were large (d ≥ 0.8). The largest effects appeared in patients experiencing pain, patients undergoing medical procedures, and pediatric populations. Only nine of the forty-nine meta-analyses met high methodological quality on AMSTAR-2 criteria, a caveat the authors explicitly flag.

Conditions with established evidence

Procedural and surgical pain is the strongest evidence domain. Schnur and colleagues found a large pooled effect size for emotional distress during medical procedures;^[16] Montgomery and colleagues' presurgical RCT in 200 breast biopsy and lumpectomy patients showed reduced intraoperative anaesthetic requirement and lower postoperative pain, nausea, fatigue, and emotional upset compared with attention control.^[10]

Gut-directed hypnotherapy for irritable bowel syndrome is the other established domain. Palsson's systematic review of seven RCTs found consistent benefits on bowel symptom scores, quality of life, and anxiety with effects maintained at twelve months;^[8] Hasan and colleagues' updated meta-analysis confirmed superiority over control and identified intervention duration and therapist training as moderators.^[4] Gut-directed hypnotherapy is now a recommended treatment option for refractory IBS in both European and North American gastroenterology guidelines.

Other supported applications include menopausal hot flashes (Elkins protocol, large effect at 12 weeks in 187 post-menopausal women),^[9] anxiety related to medical procedures,^[17] and pediatric procedural pain in oncology.^[18]

Conditions with thin or mixed evidence

Evidence for hypnotherapy as a standalone treatment for major depressive disorder is insufficient: Youssef and colleagues' 2024 systematic review of RCTs found one trial favouring hypnotherapy over Rational Emotive Behavior Therapy on remission and other trials showing no significant difference from active comparators.^[19] Smoking cessation evidence shows benefit over control but does not establish superiority to other active interventions such as nicotine replacement or CBT.^[20]

Limitations

Methodological quality across the field is uneven. Rosendahl and colleagues found that only nine of forty-nine meta-analyses met high AMSTAR-2 quality.^[1] Common limitations of primary trials include small samples, incomplete blinding, heterogeneous induction protocols, inconsistent reporting of hypnotizability stratification, and — most consequentially — absent or minimal adverse-event reporting. Richardson and colleagues' pediatric oncology review noted the same pattern: positive findings across the majority of included trials accompanied by small samples and incomplete blinding.^[18]

Publication bias is a recognized but incompletely characterized concern. The hypnosis literature includes a long tail of small studies with positive findings, and several meta-analyses report statistical signals consistent with selective reporting in subdomains beyond procedural pain and IBS [UNCITED — verify: specific funnel-plot evidence in Rosendahl umbrella review].

A separate set of limitations concerns generalizability. The strongest evidence draws on highly hypnotizable subjects in research settings; effect sizes in real-world clinical practice with unselected patient populations may be smaller. Hypnotizability stratification is rarely reported in clinical trials of suggestion-based interventions, which makes it difficult to translate findings into expected effects for an individual patient. Cultural representation in the trial literature is narrow — the bulk of trials are conducted in North American and European populations — and culturally specific framings of suggestion and trance are largely untested.

The substance-interaction literature is essentially empty: no controlled studies have characterized pharmacodynamic or pharmacokinetic interactions between hypnotherapy and any psychoactive substance class. Clinical practice norms (no acute intoxication during sessions, attention to additive sedation) are derived from first principles rather than empirical study.